Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes

被引：48

作者：

Roy, Noemi B. A. ^{[1
]}

Myerson, Saul ^{[2
]}

Schuh, Anna H. ^{[3
]}

Bignell, Patricia ^{[3
]}

Patel, Roger ^{[4
]}

Wainscoat, Jim S. ^{[5
]}

McGowan, Simon ^{[6
]}

Marchi, Emanuele ^{[6
]}

Atoyebi, Wale ^{[5
]}

Littlewood, Tim ^{[5
]}

Chacko, Joseph ^{[7
]}

Vyas, Paresh

Killick, Sally B. ^{[7
]}

机构：

[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England

[2] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

[3] Oxford Radcliffe Hosp, Haemato Mol Diagnost Serv, Oxford, England

[4] Royal Bournemouth Hosp, Dept Radiol, Bournemouth, Dorset, England

[5] Oxford Radcliffe Hosp, Dept Haematol, Oxford, England

[6] Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England

[7] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 154卷 / 04期

关键词：

myelodysplastic syndromes; magnetic resonance imaging; transfusional iron overload; hepatic R2*; cardiac R2*; MAGNETIC-RESONANCE; MYOCARDIAL IRON; ACQUIRED ANEMIAS; THALASSEMIA; CHELATION; DISEASE;

D O I：

10.1111/j.1365-2141.2011.08749.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Transfusion- dependent myelodysplastic (MDS) patients are prone to iron overload. We evaluated 43 transfused MDS patients with T2* magnetic resonance imaging scans. 81% had liver and 16.8% cardiac iron overload. Liver R2* (1000/T2*), but not cardiac R2*, was correlated with number of units transfused (r = 0.72, P < 0.0001) and ferritin (r = 0.53, P < 0.0001). The area under the curve of a time-ferritin plot was found to be much greater in patients with cardiac iron loading (median 53.7 x 10(5) Megaunits vs. 12.2 x 10(5) Megaunits, P = 0.002). HFE, HFE2, HAMP or SLC40A1 genotypes were not predictors of iron overload in these patients.

引用

页码：521 / 524

页数：4

共 50 条

[41] Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload [J].

Gattermann, Norbert .

LEUKEMIA RESEARCH, 2007, 31 :S10-S15

[42] Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study [J].

Aydinok, Yesim ;

Porter, John B. ;

Piga, Antonio ;

Elalfy, Mohsen ;

El-Beshlawy, Amal ;

Kilinc, Yurdanur ;

Viprakasit, Vip ;

Yesilipek, Akif ;

Habr, Dany ;

Quebe-Fehling, Erhard ;

Pennell, Dudley J. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) :244-253

[43] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia [J].

Chern, JPS ;

Lin, KH .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (04) :291-293

[44] Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy [J].

Jabbour, Elias ;

Garcia-Manero, Guillermo ;

Taher, Ali ;

Kantarjian, Hagop M. .

ONCOLOGIST, 2009, 14 (05) :489-496

[45] Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia [J].

Silvilairat, Suchaya ;

Charoenkwan, Pimlak ;

Saekho, Suwit ;

Tantiworawit, Adisak ;

Phrommintikul, Arintaya ;

Srichairatanakool, Somdet ;

Chattipakorn, Nipon .

PLOS ONE, 2016, 11 (10)

[46] Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox [J].

Kikuchi, Shohei ;

Kobune, Masayoshi ;

Iyama, Satoshi ;

Sato, Tsutomu ;

Murase, Kazuyuki ;

Kawano, Yutaka ;

Takada, Kohichi ;

Ono, Kaoru ;

Kaneko, Yumiko ;

Miyanishi, Koji ;

Sato, Yasushi ;

Hayashi, Tsuyoshi ;

Takimoto, Rishu ;

Kato, Junji .

FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) :643-648

[47] A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan [J].

Ho, Wan-Ling ;

Chung, Kuo-Piao ;

Yang, Szu-Sheng ;

Lu, Meng-Yao ;

Jou, Shiann-Tarng ;

Chang, Hsiu-Hao ;

Yang, Yung-Li ;

Lin, Dong-Tsamn ;

Lin, Kai-Hsin .

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (04) :221-229

[48] Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China [J].

Wang, Yihao ;

Huang, Lei ;

Hua, Yanni ;

Liu, Hui ;

Jiang, Huijuan ;

Wang, Huaquan ;

Zhang, Wei ;

Fu, Rong ;

Shao, Zonghong .

HEMATOLOGY, 2021, 26 (01) :874-880

[49] Association of Iron Overload and Oxidative Stress with Insulin Resistance in Transfusion-Dependent β-Thalassemia Major and β-Thalassemia/HbE Patients [J].

Tangvarasittichai, Surapon ;

Pimanprom, Ampai ;

Choowet, Anuchit ;

Tangvarasittichai, Orathai .

CLINICAL LABORATORY, 2013, 59 (7-8) :861-868

[50] Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload [J].

Darvishi-Khezri, Hadi ;

Naderisorki, Mohammad ;

Zahedi, Mohammad ;

Mortazavi, Parham ;

Tajik, Fatemeh ;

Nasirzadeh, Amirreza ;

Karami, Hossein .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) :1445-1453

← 1 2 3 4 5 →